Ovarian cancer, childhood
Other Names for this Disease
- Ovarian carcinoma, childhood
On this page
(AstraZeneca Pharmaceuticals LP)
The FDA has approved this product to be used in this manner.
|Use of as monotherapy for patients with deleterious or suspected deleterious germline BRCA mutated (as detected by an FDA-approved test) advanced ovarian cancer who have been treated with three or more prior lines of chemotherapy|
|More Information about this product||Drug Information Portal|